Related references
Note: Only part of the references are listed.Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?
Natalya C. Maisel et al.
ADDICTION (2013)
Medications development to treat alcohol dependence: a vision for the next decade
Raye Z. Litten et al.
ADDICTION BIOLOGY (2012)
Acamprosate for Alcohol Dependence: A Sex-Specific Meta-Analysis Based on Individual Patient Data
Barbara J. Mason et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2012)
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Stephen S. Lim et al.
LANCET (2012)
Positive and Negative Effects of Alcohol and Nicotine and Their Interactions: A Mechanistic Review
Laura L. Hurley et al.
NEUROTOXICITY RESEARCH (2012)
Varenicline decreases alcohol consumption in heavy-drinking smokers
Jennifer M. Mitchell et al.
PSYCHOPHARMACOLOGY (2012)
Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions
Allison A. Feduccia et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2012)
Epidemiology and alcohol policy in Europe
Juergen Rehm et al.
ADDICTION (2011)
Economic Costs of Excessive Alcohol Consumption in the US, 2006
Ellen E. Bouchery et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2011)
Lobeline and cytisine reduce voluntary ethanol drinking behavior in male C57BL/6J mice
Ravi K. Sajja et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control
Jelte A. Wouda et al.
PSYCHOPHARMACOLOGY (2011)
A preliminary investigation of varenicline for heavy drinking smokers
Lisa M. Fucito et al.
PSYCHOPHARMACOLOGY (2011)
The relation between different dimensions of alcohol consumption and burden of disease: an overview
Juergen Rehm et al.
ADDICTION (2010)
Structural differences determine the relative selectivity of nicotinic compounds for native α4β2*-, α6β2*-, α3β4*- and α7-nicotine acetylcholine receptors
Sharon R. Grady et al.
NEUROPHARMACOLOGY (2010)
Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers
Sherry A. McKee et al.
BIOLOGICAL PSYCHIATRY (2009)
The Smoking Cessation Medication Varenicline Attenuates Alcohol and Nicotine Interactions in the Rat Mesolimbic Dopamine System
Mia Ericson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Alcohol and Global Health 1 Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders
Juergen Rehm et al.
LANCET (2009)
Effects of Mecamylamine on Alcohol Consumption and Preference in Male C57BL/6J Mice
Justin M. Farook et al.
PHARMACOLOGY (2009)
Effect of transdermal nicotine replacement on alcohol responses and alcohol self-administration
Sherry A. McKee et al.
PSYCHOPHARMACOLOGY (2008)
Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study
Lara A. Ray et al.
PSYCHOPHARMACOLOGY (2007)
Varenicline, an α402 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking
Pia Steensland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Varenicline is a partial agonist at α4β2 and a full agonist at α7 neuronal nicotinic receptors
Karla B. Mihalak et al.
MOLECULAR PHARMACOLOGY (2006)
Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation -: A randomized controlled trial
David Gonzales et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Does effect size in naltrexone trials for alcohol dependence differ for single-site vs. multi-center studies?
R Feinn et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2005)
The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002
BF Grant et al.
DRUG AND ALCOHOL DEPENDENCE (2004)
Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol
O Blomqvist et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2002)
Involvement of nicotinic receptors in alcohol self-administration
AD Lê et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2000)
Share Paper
